IRIS UniCatt

De Candia, Erica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.808
AS - Asia 2.754
EU - Europa 2.701
SA - Sud America 549
Continente sconosciuto - Info sul continente non disponibili 148
AF - Africa 84
OC - Oceania 17
Totale 11.061
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.613
SG - Singapore 1.271
IT - Italia 589
CN - Cina 564
BR - Brasile 454
DE - Germania 453
PL - Polonia 383
SE - Svezia 382
VN - Vietnam 249
FR - Francia 181
UA - Ucraina 142
IE - Irlanda 137
GB - Regno Unito 131
IN - India 104
CA - Canada 92
ID - Indonesia 88
BD - Bangladesh 84
JP - Giappone 81
FI - Finlandia 79
RU - Federazione Russa 67
HK - Hong Kong 60
MX - Messico 39
AR - Argentina 35
NL - Olanda 35
IQ - Iraq 32
TR - Turchia 32
IL - Israele 26
AT - Austria 23
PK - Pakistan 21
BE - Belgio 20
IR - Iran 20
ZA - Sudafrica 20
EC - Ecuador 18
ES - Italia 17
KR - Corea 17
AU - Australia 16
EG - Egitto 16
JO - Giordania 14
PH - Filippine 14
HU - Ungheria 12
MA - Marocco 12
UZ - Uzbekistan 12
VE - Venezuela 12
CH - Svizzera 10
CR - Costa Rica 9
MY - Malesia 9
RO - Romania 9
CO - Colombia 8
JM - Giamaica 8
SA - Arabia Saudita 8
TT - Trinidad e Tobago 8
CL - Cile 7
GT - Guatemala 7
KE - Kenya 7
PR - Porto Rico 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
LB - Libano 6
BH - Bahrain 5
CI - Costa d'Avorio 5
EE - Estonia 5
HN - Honduras 5
LT - Lituania 5
NI - Nicaragua 5
NP - Nepal 5
PY - Paraguay 5
UY - Uruguay 5
CZ - Repubblica Ceca 4
MK - Macedonia 4
SC - Seychelles 4
SY - Repubblica araba siriana 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GP - Guadalupe 3
PS - Palestinian Territory 3
TW - Taiwan 3
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
BB - Barbados 2
BG - Bulgaria 2
CG - Congo 2
CW - ???statistics.table.value.countryCode.CW??? 2
DZ - Algeria 2
GE - Georgia 2
KW - Kuwait 2
MN - Mongolia 2
NG - Nigeria 2
PE - Perù 2
SV - El Salvador 2
BN - Brunei Darussalam 1
BS - Bahamas 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
GI - Gibilterra 1
GR - Grecia 1
Totale 10.901
Salva come PNG Salva come JPEG
Città #
Singapore 756
Ashburn 586
San Jose 427
Warsaw 374
Chandler 333
Dublin 131
Los Angeles 124
Council Bluffs 120
Beijing 118
Rome 110
New York 108
Fairfield 106
Wilmington 91
San Mateo 90
Jacksonville 85
Ho Chi Minh City 84
Jakarta 72
Tokyo 69
Hanoi 66
Lauterbourg 66
Milan 63
Woodbridge 62
Hefei 60
Ann Arbor 59
Nanjing 59
Munich 56
Hong Kong 54
Houston 54
Seattle 54
Boston 52
Buffalo 52
Dallas 52
Chicago 45
Marseille 42
Santa Clara 42
Boardman 39
Frankfurt am Main 39
São Paulo 38
Moscow 36
Princeton 36
Dearborn 33
The Dalles 33
Cambridge 28
Cattolica 28
Redwood City 28
North Bergen 27
Atlanta 26
Helsinki 25
London 25
Hyderabad 23
Toronto 22
Denver 21
Phoenix 21
Lawrence 20
Nuremberg 20
San Francisco 19
Nanchang 18
Rio de Janeiro 18
Montreal 17
Bologna 16
Brussels 16
Seoul 16
Tukwila 16
Augusta 15
Brooklyn 15
St Louis 15
Da Nang 14
Naples 14
Shanghai 14
Turku 14
Hangzhou 13
Kent 13
Redmond 13
Amman 12
Andover 12
Curitiba 12
Guangzhou 12
Lappeenranta 12
Nürnberg 12
Pune 12
Brasília 11
Chennai 11
Izmir 11
Las Vegas 11
Norwalk 11
San Diego 11
Baghdad 10
Bari 10
Bremen 10
Budapest 10
Florence 10
Guarulhos 10
Mountain View 10
Tashkent 10
Vienna 10
Washington 10
Zhengzhou 10
Cleveland 9
Johannesburg 9
Mexico City 9
Totale 5.853
Salva come PNG Salva come JPEG
Nome #
Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients 479
Correlation between platelet phenotype and NBEAL2 genotype in patients with congenital thrombocytopenia and α-granule deficiency 329
Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome 310
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 294
Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study 244
Eltrombopag for the treatment of inherited thrombocytopenias: a phase 2 clinical trial 229
Data on the application of early coagulation support protocol in the management of major trauma patients 217
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 199
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 190
Murine platelet production is suppressed by S1P release in the hematopoietic niche, not facilitated by blood S1P sensing. 188
Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D9D3 and D4 domains 187
Effect of fibrinogen concentration on the velocity of platelet aggregation. 178
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET) 173
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 172
Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: clinical characteristics, antibody profiles and estimate of the risk of recurrence 171
Heparin induced thrombocytopenia: Position paper from the Italian Society on Thrombosis and Haemostasis (SISET) 169
Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group 168
Platelets and Neurodegenerative Diseases: Current Knowledge and Future Perspectives 167
Functional role of protease activated receptors in vascular biology 164
MORE EARLY BLEEDS ASSOCIATED WITH HIGH BASELINE DIRECT ORAL ANTICOAGULANT LEVELS IN ATRIAL FIBRILLATION: THE MAS STUDY 163
Autoimmune disorders of platelet function: systematic review of cases of acquired Glanzmann thrombasthenia and acquired delta storage pool disease 163
Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients? 160
Direct oral anticoagulants and therapeutic adherence: do not let your guard down 155
Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project 152
Detection of Platelet-Activating Antibodies Associated with Vaccine-Induced Thrombotic Thrombocytopenia by Flow Cytometry: An Italian Experience 152
Structural and funtional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib 148
Evaluation of Novel Guanidino-Containing Isonipecotamide Inhibitors of Blood Coagulation Factors against SARS-CoV-2 Virus Infection 146
Mechanisms of platelet activation by thrombin: a short history 145
Hemophilia A and von Willebrand deficiency: therapeutic implications 144
Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma. 141
Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo" 141
Early coagulation support protocol: A valid approach in real-life management of major trauma patients. Results from two Italian centres 140
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 140
MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations 139
Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillations: the MAS study 136
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives 136
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study 136
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study 132
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk 130
Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experience 128
Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders. 124
Extended coagulation profile of children with Long Covid: a prospective study 123
Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector. 123
Portal vein thrombosis occurrence in a cirrhotic patient during treatment with rivaroxaban 120
Gut Microbiome Diversity and Composition Correlates With Time in the Therapeutic Range in Patients on Warfarin Treatment: A Pilot Study 120
Allosteric equilibria in the binding reaction of fibrinogen to platelets. 119
The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology 118
Thrombin interaction with platelet GpIB: role of the heparin binding domain. 117
Rituximab for treatment of autoimmune acquired platelet function disorders: description of two cases of acquired Glanzmann thrombasthenia and one case of acquired delta storage pool disease 115
Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSC 113
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 111
Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome 111
Binding of human alpha-thrombin to platelet GpIb: energetics and functional effects. 110
Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease. 110
Circulating Activated Platelets in Children With Long Covid: A Case-Controlled Preliminary Observation 108
NETosis in arterial and venous thrombosis: a one size fits all mechanism? 108
Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients 108
Bleeding and thrombotic events in a patient with lupus anticoagulant-associated hypoprothrombinemia and antiphospholipid antibody syndromes: managing hemostasis between Scylla and Charybdis 104
MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations 100
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders 100
Association of human leucocyte antigen loci with vaccine-induced immune thrombotic thrombocytopenia: Potential role of the interaction between platelet factor 4-derived peptides and MHC-II 97
INHIBITION OF FIBRINOGEN BINDING TO HUMAN-PLATELETS BY BLOCKAGE OF NA+/H+ EXCHANGE. 96
Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome 93
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 90
Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia:Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 89
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives 87
Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y12 and Link to Residual Platelet Reactivity 86
Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets 84
Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study 82
Atrial Fibrillation, Heart Failure Phenotypes, and Mortality Risk in the Nationwide START Registry: A Propensity Score Matching Analysis 80
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA). 80
Why the disorder induced by GATA1 Arg216Gln mutation should be called "X-linked thrombocytopenia with thalassemia" rather than "X-linked gray platelet syndrome 80
COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from the Apidulcis study 78
Long-term left ventricular thrombosis resolution in patients receiving vitamin k antagonists: a multicenter observational study 62
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry 59
Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders 51
Thrombotic Risk and Coagulation Imbalance in Cirrhosis and Hepatocellular Carcinoma: Clinical Implications and Management 38
Drug-related hepatotoxicity risk in elderly patients with atrial fibrillation: insights from the nationwide Italian START registry 35
Early Platelet Dysfunction in Sepsis: An ICU Pilot Study 34
Effectiveness of direct oral anticoagulants for all-cause mortality and cardiovascular events in overweight and obese patients with atrial fibrillation: Insight from the nationwide START registry 33
Real-world use of direct oral anticoagulants in atrial fibrillation patients with moderate/severe chronic kidney disease: a propensity score matched analysis from the START registry 28
PO-54 - Clinical and laboratory characterization of platelet dysfunction caused by ibrutinib treatment in patients with chronic lymphocytic leukemia 27
Thrombocytopenia in carriers and patients with antiphospholipid syndrome: insights from the nationwide START-APS registry 23
Autoimmune disorders of platelet function: systematic review of cases of acquired Glanzmann thrombasthenia and acquired delta storage pool disease 18
Multiple arterial thrombosis in a 33-year-old woman with anasarca, systemic lupus erythematosus, and acquired coagulopathy 14
Totale 11.061
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.655
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.655
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022471 0 0 0 0 34 18 18 111 23 39 112 116
2022/20231.048 141 135 71 141 85 126 74 84 129 12 33 17
2023/2024657 19 161 27 34 28 70 48 16 12 26 52 164
2024/20251.235 24 32 113 64 65 46 42 49 172 133 302 193
2025/20263.845 527 155 225 391 638 205 659 173 225 251 204 192
2026/20271.744 272 475 243 631 123 0 0 0 0 0 0 0
Totale 11.061